custom search
REVERSED
Tech Center 1700 Chemical & Materials Engineering
1787 Ex Parte Yoon et al 12297042 - (D) OGDEN 103 HARNESS, DICKEY, & PIERCE, P.L.C STACHEL, KENNETH J
Tech Center 2800 Semiconductors, Electrical and Optical Systems and Components
2864 Ex Parte Chankaya et al 13007099 - (D) OWENS 103 Reising Ethington PC PEREZ BERMUDEZ, YARITZA H
Tech Center 3700 Mechanical Engineering, Manufacturing, and Products & Design
3742 Ex Parte FURUTA et al 14031648 - (D) JESCHKE 103 HAUPTMAN HAM, LLP LAFLAME JR, MICHAEL A
AFFIRMED-IN-PART
Tech Center 1700 Chemical & Materials Engineering
1792 Ex Parte Mafi 13616648 - (D) OWENS 103 103 Ryan Alley IP SMITH, PRESTON
Tech Center 2400 Networking, Multiplexing, Cable, and Security
2454 Ex Parte Erb et al 13373610 - (D) WINSOR 103 101/103 41.50 101 PERRY + CURRIER INC. (FOR MITEL) KHAN, AFTAB N
AFFIRMED
Tech Center 2100 Computer Architecture and Software
2194 Ex Parte Gopal et al 12130568 - (D) BUI 103 MERCHANT & GOULD (MICROSOFT) ONAT, UMUT
Tech Center 2600 Communications
2621 Ex Parte Mauro et al 13787756 - (D) BUI 103 Banner & Witcoff, Ltd. LUI, DONNA V
Tech Center 3600 Transportation, Construction, Electronic Commerce, Agriculture, National Security, and License & Review
3622 Ex Parte Summer et al 14738807 - (D) FETTING 112(1)/112(2) 101/103 KOLISCH HARTWELL, P.C. DURAN, ARTHUR D
Mental perceptions of what data represent are non-functional and given no weight. King Pharms., Inc. v. Eon Labs, Inc., 616 F.3d 1267, 1279 (Fed. Cir. 2010) (“[T]he relevant question is whether ‘there exists any new and unobvious functional relationship between the printed matter and the substrate.’” (quoting In re Gulack, 703 F.2d 1381, 1386 (Fed. Cir. 1983));
King Pharmaceuticals Inc. v. Eon Labs Inc., 616 F.3d 1267, 95 USPQ2d 1833 (Fed. Cir. 2010) 2111.05 , 2112.01
Gulack, In re, 703 F.2d 1381, 217 USPQ 401 (Fed. Cir. 1983) 2112.01
3687 Ex Parte Ferguson 12077863 - (D) FETTING 101 Anthony John Ferguson CRAWLEY, TALIA F
3689 Ex Parte Hamilton et al 12173419 - (D) FETTING 101/103 Driggs, Hogg, Daugherty & Del Zoppo Co., L.P.A. ARAQUE JR, GERARDO
Tech Center 3700 Mechanical Engineering, Manufacturing, and Products & Design
3711 Ex Parte Vu 14692728 - (D) STEPINA 102 102/103 LAMORTE & ASSOCIATES P.C. MENDIRATTA, VISHU K
REHEARING
DENIED
Tech Center 2400 Networking, Multiplexing, Cable, and Security
2434 Ex Parte Harjula et al 14034010 - (D) JURGOVAN 103 SCHWEGMAN LUNDBERG & WOESSNER, P.A. GETACHEW, ABIY
SEARCH
PTAB.US: Decisions of PTAB Patent Trial and Appeal Board
Li & Cai
Showing posts with label king. Show all posts
Showing posts with label king. Show all posts
Wednesday, December 27, 2017
Thursday, August 18, 2016
king
custom search
REVERSED
Tech Center 1600 Biotechnology and Organic Chemistry
1612 Ex Parte Stephenson 09489310 - (D) HANLON 103 THE PROCTER & GAMBLE COMPANY LIU, TRACY
On appeal, the Examiner also directs our attention to King Pharm., Inc. v. Eon Labs, Inc., 616 F.3d 1267 (Fed. Cir. 2010). The Examiner finds that "Applicant's step (a) in claim 23 of a physician or dental professional 'informing' a patient to orally administer a carbonated beverage for its inherent property of treating dental erosion is not patentable per the King Pharm. holding." Ans. 8. distinguishing language," in contrast to Jansen. Decision 6 (quoting Office Action dated June 6, 2005, at 2).
The facts in King, however, are different from the facts in this case. In King, the following claim limitation was at issue: "'informing the patient that administration of a therapeutically effective amount of metaxalone in a pharmaceutical composition with food results in an increase in the maximal plasma concentration ( Cmax) and extent of absorption ... compared to administration without food."' King, 616 F.3d at 1277 (emphasis added). The Court found that taking metaxalone with food was known in the art. , 616 F.3d at 1275. Thus, the Court found that "[i]nforming a patient about the benefits of a drug in no way transforms the process of taking the drug with food. Irrespective of whether the patient is informed about the benefits, the actual method, taking metaxalone with food, is the same." King, 616 F.3d at 1279.
In this case, claim 23 recites a "directing" step, not an "informing" step as in King. The method recited in claim 23 comprises, inter alia, the step of "a physician or dental profession directing a human, in need thereof . .. , to orally administer an effective amount of [the claimed beverage composition] at least once daily for the purpose of treating dental erosion."
King Pharmaceuticals Inc. v. Eon Labs Inc., 616 F.3d 1267, 95 USPQ2d 1833 (Fed. Cir. 2010) 2111.05 , 2112.01
Tech Center 1700 Chemical & Materials Engineering
1779 Ex Parte Merritt et al 11933904 - (D) ROESEL 103 REINHART BOERNER VAN DEUREN P.C. ORME, PATRICK JAMES
Tech Center 2100 Computer Architecture and Software
2173 Ex Parte Basir et al 13206199 - (D) YAP 102/103 CARLSON, GASKEY & OLDS, P,C GATTEW, ASTEW AY T
Tech Center 2600 Communications
2683 Ex Parte Ramsdell et al 12944837 - (D) MacDONALD 103/double patenting FERENCE & ASSOCIATES LLC SYED, NABIL H
Tech Center 2800 Semiconductors, Electrical and Optical Systems and Components
2875 Ex Parte BRASS et al 12503304 - (D) HASTINGS 103 KATTEN MUCHIN ROSENMAN LLP PAYNE, SHARONE
Tech Center 3600 Transportation, Construction, Electronic Commerce, Agriculture, National Security, and License & Review
3626 Ex Parte HONG et al 12247726 - (D) SILVERMAN 103 THE FARRELL LAW FIRM, P.C. NAJARIAN, LENA
3628 Ex Parte Horree et al 11966335 - (D) FETTING 112(1)/103 PITNEY BOWES INC HARRINGTON, MICHAEL P
Tech Center 3700 Mechanical Engineering, Manufacturing, and Products & Design
3762 Ex Parte Schwaibold et al 12225980 - (D) HOFFMANN 103 Abel Law Group, LLP MAHMOOD, NADIA AHMAD
3762 Ex Parte Erickson et al 12245208 - (D) KERINS 112(1)/103 ST. JUDE MEDICAL NEUROMODULA TION DIVISION VOORHEES, CATHERINE M
3766 Ex Parte Stubbs et al 12917101 - (D) SCHOPPER 103 SCHWEGMAN LUNDBERG & WOESSNER/BSC PIATESKI, ERIN M
3779 Ex Parte Segawa 13711669 - (D) PER CURIAM 102/103 SCULLY SCOTT MURPHY & PRESSER, PC BOLER, RYNAE E
AFFIRMED-IN-PART
Tech Center 1600 Biotechnology and Organic Chemistry
1651 Ex Parte McIntyre et al 13617611 - (D) LAVIER 102 103 CARELLA, BYRNE, CECCHI, OLSTEIN, BRODY & AGNELLO FAN, LYNN Y
Tech Center 2400 Networking, Multiplexing, Cable, and Security
2426 Ex Parte Hill et al 12917678 - (D) MORGAN 103 103 ROGITZ & ASSOCIA TES OCAK, ADIL
Tech Center 2800 Semiconductors, Electrical and Optical Systems and Components
2833 Ex Parte BERTRAM et al 13211843 - (D) DELMENDO 103 103 41.50 112(2) Muncy, Geissler, Olds & Lowe, P,C, FIGUEROA, FELIX 0
Tech Center 3600 Transportation, Construction, Electronic Commerce, Agriculture, National Security, and License & Review
3626 Ex Parte Claus et al 11839074 - (D) FETTING 103 103 ABBOTT MEDICAL OPTICS INC. RAJ, RAJIV J
AFFIRMED
Tech Center 1600 Biotechnology and Organic Chemistry
1618 Ex Parte Cunningham et al 12982058 - (D) COTTA 103 KIMBERLY-CLARK WORLDWIDE, INC. CABRAL, ROBERTS
1618 Ex Parte Masini-Eteve 11249122 - (D) MAJORS 103 Foley & Lardner LLP WESTERBERG, NISSA M
1619 Ex Parte Copp-Howland 13677831 - (D) TOWNSEND 103/double patenting Covidien ALAWADI, SARAH
1621 Ex Parte Hacker et al 12837672 - (D) SMITH 103 MMWV IP, LLC QAZI, SABIHA NAIM
1628 Ex Parte Padilla et al 13462375 - (D) LAVIER 103/double patenting THOMPSON HINE L.L.P. RODRIGUEZ, RAYNA B
1634 Ex Parte Atwood 13691048 - (D) ADAMS 102/103 101 Andrus Intellectual Property Law, LLP POHNERT, STEVEN C
1644 Ex Parte GOLDENBERG et al 13349755 - (D) FREDMAN 112(1) 103/double patenting Rossi, Kimms & McDowell LLP SCHWADRON, RONALD B
1646 Ex Parte Qiu et al 11578257 - (D) COTTA 103 Bozicevic, Field & Francis LLP Arena Pharmaceuticals, Inc. LI, RUIXIANG
1652 Ex Parte McAuliffe et al 12528968 - (D) SCHNEIDER 103 DANISCO US INC ROBINSON, HOPE A
1652 Ex Parte Hansen et al 13051317 - (D) ADAMS 112(1)/112(2) 112(1)/double patenting Agilent Technologies, Inc, RAMIREZ, DELIA M
Tech Center 1700 Chemical & Materials Engineering
1733 Ex Parte Luo et al 13194079 - (D) HEANEY 103 BrooksGroup ZHU, WEIPING
1765 Ex Parte DeSanto et al 12869363 - (D) McMANUS 103 CLARK HILL PLC NUTTER, NATHAN M
1791 Ex Parte Friesen et al 11813268 - (D) ROESEL 103 COLGATE-PALMOLIVE COMPANY SAYALA, CHHAYA D
1791 Ex Parte Thorengaard et al 13352211 - (D) TIMM res judicata 103 ST ONGE STEW ARD JOHNSTON & REENS, LLC DEES, NIKKI H
1791 Ex Parte Langley et al 13579330 - (D) HEANEY 103 Richard Blakely Glasgow TARAZANO, DONALD LAWRENCE
Tech Center 2100 Computer Architecture and Software
2117 Ex Parte Lida et al 12689359 - (D) NAPPI 112(1)/103 Active Knowledge Ltd, TABONE JR, JOHN J
2166 Ex Parte Yin et al 11462387 - (D) STEPHENS 103 TERRILE, CANNATTI, CHAMBERS & HOLLAND, LLP CHEEMA, AZAM M
2179 Ex Parte Jung et al 11977748 - (D) HAAPALA 112(2)/103/double patenting Constellation Law Group, PLLC THERIAULT, STEVEN B
2191 Ex Parte Bogdan 12327008 - (D) HOMERE 112(1) 103 AT & T Legal Department - FKM WU, JUNCHUN
Tech Center 2400 Networking, Multiplexing, Cable, and Security
2427 Ex Parte Setos 12735566 - (D) SZPONDOWSKI 102/103 Cantor Colburn LLP - Fox Entertainment Group KURIEN, CHRISTEN A
2476 Ex Parte Ducharme 11864946 - (D) JEFFERY 103 Garlick & Markison (VIXS) SLOMS, NICHOLAS
2479 Ex Parte SEYAMA et al 12484571 - (D) MacDONALD 102/103 MYERS WOLIN, LLC CEHIC, KENAN
2483 Ex Parte Adachi et al 12644464 - (D) BEAMER 103 BGL/NTT DoCoMo, Inc BAILEY, FREDERICK D
Tech Center 2600 Communications
2666 Ex Parte Chandrasekaran et al 12470673 - (D) COURTENAY 103 HONEYWELL/HUSCH DULANEY, KATHLEEN YUAN
2689 Ex Parte Cinbis et al 13190737 - (D) WINSOR 103 Medtronic, Inc. (CRDM) CASILLASHERNANDEZ, OMAR
2692 Ex Parte PARK 12707854 - (D) MacDONALD 103 H.C. PARK & ASSOCIATES, PLC SHAH, PRIYANK J
2697 Ex Parte KRAH et al 13244072 - (D) HOMERE 103 APPLE c/o MORRISON & FOERSTER LLP LA YANG, NAN-YING
Tech Center 2800 Semiconductors, Electrical and Optical Systems and Components
2878 Ex Parte FISCHER et al 13303530 - (D) STEPHENS 112(1) NORTON ROSE FULBRIGHT US LLP CHAVEZ, RENEE D
2887 Ex Parte Martin et al 13685750 - (D) KENNY 103 Zebra Technologies Corporation BROWN, CLAUDE J
Tech Center 3600 Transportation, Construction, Electronic Commerce, Agriculture, National Security, and License & Review
3623 Ex Parte Angell et al 11861966 - (D) FETTING 103 YEE AND ASSOCIATES, P.C. BOSWELL, BETH V
3657 Ex Parte Thye-Moormann 12520910 - (D) JESCHKE 103 112(2) 41.50 112(2) OBLON, MCCLELLAND, MAIER & NEUSTADT, LLP, BURCH, MELODY M
Tech Center 3700 Mechanical Engineering, Manufacturing, and Products & Design
3726 Ex Parte Tharp et al 13194401 - (D) HOSKINS 103 41.50 103 MICHAEL BEST & FRIEDRICH LLP (Mke) OMGBA, ESSAMA
3737 Ex Parte Allain et al 12376308 - (D) HOELTER 103 PHILIPS INTELLECTUAL PROPERTY & STANDARDS HUYNH, PHONG KY
3745 Ex Parte Cahill et al 12867857 - (D) PLENZLER 103 KINNEY & LANGE, P.A. JAGODA, AARON H
REISSUE
AFFIRMED
Tech Center 3600 Transportation, Construction, Electronic Commerce, Agriculture, National Security, and License & Review
3683 Ex Parte Deferme 7,070,029 10/662,544 11879727 - (D) BARRETT 251 Harness, Dickey & Pierce, PLC (Tenneco) DOERRLER, WILLIAM CHARLES original KRAMER, DEVON C
Tech Center 3700 Mechanical Engineering, Manufacturing, and Products & Design
3738 HEINZ KURZ GmbH MEDIZINTECHNIK Patent Owner, Appellant Ex Parte KURZ 6,579,317 09/933,619 14326632 - (D) SONG 103 STRIKER, STRIKER & STENBY JASTRZAB, JEFFREY R original GHERBI, SUZETTE JAIME J
REVERSED
Tech Center 1600 Biotechnology and Organic Chemistry
1612 Ex Parte Stephenson 09489310 - (D) HANLON 103 THE PROCTER & GAMBLE COMPANY LIU, TRACY
On appeal, the Examiner also directs our attention to King Pharm., Inc. v. Eon Labs, Inc., 616 F.3d 1267 (Fed. Cir. 2010). The Examiner finds that "Applicant's step (a) in claim 23 of a physician or dental professional 'informing' a patient to orally administer a carbonated beverage for its inherent property of treating dental erosion is not patentable per the King Pharm. holding." Ans. 8. distinguishing language," in contrast to Jansen. Decision 6 (quoting Office Action dated June 6, 2005, at 2).
The facts in King, however, are different from the facts in this case. In King, the following claim limitation was at issue: "'informing the patient that administration of a therapeutically effective amount of metaxalone in a pharmaceutical composition with food results in an increase in the maximal plasma concentration ( Cmax) and extent of absorption ... compared to administration without food."' King, 616 F.3d at 1277 (emphasis added). The Court found that taking metaxalone with food was known in the art. , 616 F.3d at 1275. Thus, the Court found that "[i]nforming a patient about the benefits of a drug in no way transforms the process of taking the drug with food. Irrespective of whether the patient is informed about the benefits, the actual method, taking metaxalone with food, is the same." King, 616 F.3d at 1279.
In this case, claim 23 recites a "directing" step, not an "informing" step as in King. The method recited in claim 23 comprises, inter alia, the step of "a physician or dental profession directing a human, in need thereof . .. , to orally administer an effective amount of [the claimed beverage composition] at least once daily for the purpose of treating dental erosion."
King Pharmaceuticals Inc. v. Eon Labs Inc., 616 F.3d 1267, 95 USPQ2d 1833 (Fed. Cir. 2010) 2111.05 , 2112.01
Tech Center 1700 Chemical & Materials Engineering
1779 Ex Parte Merritt et al 11933904 - (D) ROESEL 103 REINHART BOERNER VAN DEUREN P.C. ORME, PATRICK JAMES
Tech Center 2100 Computer Architecture and Software
2173 Ex Parte Basir et al 13206199 - (D) YAP 102/103 CARLSON, GASKEY & OLDS, P,C GATTEW, ASTEW AY T
Tech Center 2600 Communications
2683 Ex Parte Ramsdell et al 12944837 - (D) MacDONALD 103/double patenting FERENCE & ASSOCIATES LLC SYED, NABIL H
Tech Center 2800 Semiconductors, Electrical and Optical Systems and Components
2875 Ex Parte BRASS et al 12503304 - (D) HASTINGS 103 KATTEN MUCHIN ROSENMAN LLP PAYNE, SHARONE
Tech Center 3600 Transportation, Construction, Electronic Commerce, Agriculture, National Security, and License & Review
3626 Ex Parte HONG et al 12247726 - (D) SILVERMAN 103 THE FARRELL LAW FIRM, P.C. NAJARIAN, LENA
3628 Ex Parte Horree et al 11966335 - (D) FETTING 112(1)/103 PITNEY BOWES INC HARRINGTON, MICHAEL P
Tech Center 3700 Mechanical Engineering, Manufacturing, and Products & Design
3762 Ex Parte Schwaibold et al 12225980 - (D) HOFFMANN 103 Abel Law Group, LLP MAHMOOD, NADIA AHMAD
3762 Ex Parte Erickson et al 12245208 - (D) KERINS 112(1)/103 ST. JUDE MEDICAL NEUROMODULA TION DIVISION VOORHEES, CATHERINE M
3766 Ex Parte Stubbs et al 12917101 - (D) SCHOPPER 103 SCHWEGMAN LUNDBERG & WOESSNER/BSC PIATESKI, ERIN M
3779 Ex Parte Segawa 13711669 - (D) PER CURIAM 102/103 SCULLY SCOTT MURPHY & PRESSER, PC BOLER, RYNAE E
AFFIRMED-IN-PART
Tech Center 1600 Biotechnology and Organic Chemistry
1651 Ex Parte McIntyre et al 13617611 - (D) LAVIER 102 103 CARELLA, BYRNE, CECCHI, OLSTEIN, BRODY & AGNELLO FAN, LYNN Y
Tech Center 2400 Networking, Multiplexing, Cable, and Security
2426 Ex Parte Hill et al 12917678 - (D) MORGAN 103 103 ROGITZ & ASSOCIA TES OCAK, ADIL
Tech Center 2800 Semiconductors, Electrical and Optical Systems and Components
2833 Ex Parte BERTRAM et al 13211843 - (D) DELMENDO 103 103 41.50 112(2) Muncy, Geissler, Olds & Lowe, P,C, FIGUEROA, FELIX 0
Tech Center 3600 Transportation, Construction, Electronic Commerce, Agriculture, National Security, and License & Review
3626 Ex Parte Claus et al 11839074 - (D) FETTING 103 103 ABBOTT MEDICAL OPTICS INC. RAJ, RAJIV J
AFFIRMED
Tech Center 1600 Biotechnology and Organic Chemistry
1618 Ex Parte Cunningham et al 12982058 - (D) COTTA 103 KIMBERLY-CLARK WORLDWIDE, INC. CABRAL, ROBERTS
1618 Ex Parte Masini-Eteve 11249122 - (D) MAJORS 103 Foley & Lardner LLP WESTERBERG, NISSA M
1619 Ex Parte Copp-Howland 13677831 - (D) TOWNSEND 103/double patenting Covidien ALAWADI, SARAH
1621 Ex Parte Hacker et al 12837672 - (D) SMITH 103 MMWV IP, LLC QAZI, SABIHA NAIM
1628 Ex Parte Padilla et al 13462375 - (D) LAVIER 103/double patenting THOMPSON HINE L.L.P. RODRIGUEZ, RAYNA B
1634 Ex Parte Atwood 13691048 - (D) ADAMS 102/103 101 Andrus Intellectual Property Law, LLP POHNERT, STEVEN C
1644 Ex Parte GOLDENBERG et al 13349755 - (D) FREDMAN 112(1) 103/double patenting Rossi, Kimms & McDowell LLP SCHWADRON, RONALD B
1646 Ex Parte Qiu et al 11578257 - (D) COTTA 103 Bozicevic, Field & Francis LLP Arena Pharmaceuticals, Inc. LI, RUIXIANG
1652 Ex Parte McAuliffe et al 12528968 - (D) SCHNEIDER 103 DANISCO US INC ROBINSON, HOPE A
1652 Ex Parte Hansen et al 13051317 - (D) ADAMS 112(1)/112(2) 112(1)/double patenting Agilent Technologies, Inc, RAMIREZ, DELIA M
Tech Center 1700 Chemical & Materials Engineering
1733 Ex Parte Luo et al 13194079 - (D) HEANEY 103 BrooksGroup ZHU, WEIPING
1765 Ex Parte DeSanto et al 12869363 - (D) McMANUS 103 CLARK HILL PLC NUTTER, NATHAN M
1791 Ex Parte Friesen et al 11813268 - (D) ROESEL 103 COLGATE-PALMOLIVE COMPANY SAYALA, CHHAYA D
1791 Ex Parte Thorengaard et al 13352211 - (D) TIMM res judicata 103 ST ONGE STEW ARD JOHNSTON & REENS, LLC DEES, NIKKI H
1791 Ex Parte Langley et al 13579330 - (D) HEANEY 103 Richard Blakely Glasgow TARAZANO, DONALD LAWRENCE
Tech Center 2100 Computer Architecture and Software
2117 Ex Parte Lida et al 12689359 - (D) NAPPI 112(1)/103 Active Knowledge Ltd, TABONE JR, JOHN J
2166 Ex Parte Yin et al 11462387 - (D) STEPHENS 103 TERRILE, CANNATTI, CHAMBERS & HOLLAND, LLP CHEEMA, AZAM M
2179 Ex Parte Jung et al 11977748 - (D) HAAPALA 112(2)/103/double patenting Constellation Law Group, PLLC THERIAULT, STEVEN B
2191 Ex Parte Bogdan 12327008 - (D) HOMERE 112(1) 103 AT & T Legal Department - FKM WU, JUNCHUN
Tech Center 2400 Networking, Multiplexing, Cable, and Security
2427 Ex Parte Setos 12735566 - (D) SZPONDOWSKI 102/103 Cantor Colburn LLP - Fox Entertainment Group KURIEN, CHRISTEN A
2476 Ex Parte Ducharme 11864946 - (D) JEFFERY 103 Garlick & Markison (VIXS) SLOMS, NICHOLAS
2479 Ex Parte SEYAMA et al 12484571 - (D) MacDONALD 102/103 MYERS WOLIN, LLC CEHIC, KENAN
2483 Ex Parte Adachi et al 12644464 - (D) BEAMER 103 BGL/NTT DoCoMo, Inc BAILEY, FREDERICK D
Tech Center 2600 Communications
2666 Ex Parte Chandrasekaran et al 12470673 - (D) COURTENAY 103 HONEYWELL/HUSCH DULANEY, KATHLEEN YUAN
2689 Ex Parte Cinbis et al 13190737 - (D) WINSOR 103 Medtronic, Inc. (CRDM) CASILLASHERNANDEZ, OMAR
2692 Ex Parte PARK 12707854 - (D) MacDONALD 103 H.C. PARK & ASSOCIATES, PLC SHAH, PRIYANK J
2697 Ex Parte KRAH et al 13244072 - (D) HOMERE 103 APPLE c/o MORRISON & FOERSTER LLP LA YANG, NAN-YING
Tech Center 2800 Semiconductors, Electrical and Optical Systems and Components
2878 Ex Parte FISCHER et al 13303530 - (D) STEPHENS 112(1) NORTON ROSE FULBRIGHT US LLP CHAVEZ, RENEE D
2887 Ex Parte Martin et al 13685750 - (D) KENNY 103 Zebra Technologies Corporation BROWN, CLAUDE J
Tech Center 3600 Transportation, Construction, Electronic Commerce, Agriculture, National Security, and License & Review
3623 Ex Parte Angell et al 11861966 - (D) FETTING 103 YEE AND ASSOCIATES, P.C. BOSWELL, BETH V
3657 Ex Parte Thye-Moormann 12520910 - (D) JESCHKE 103 112(2) 41.50 112(2) OBLON, MCCLELLAND, MAIER & NEUSTADT, LLP, BURCH, MELODY M
Tech Center 3700 Mechanical Engineering, Manufacturing, and Products & Design
3726 Ex Parte Tharp et al 13194401 - (D) HOSKINS 103 41.50 103 MICHAEL BEST & FRIEDRICH LLP (Mke) OMGBA, ESSAMA
3737 Ex Parte Allain et al 12376308 - (D) HOELTER 103 PHILIPS INTELLECTUAL PROPERTY & STANDARDS HUYNH, PHONG KY
3745 Ex Parte Cahill et al 12867857 - (D) PLENZLER 103 KINNEY & LANGE, P.A. JAGODA, AARON H
REISSUE
AFFIRMED
Tech Center 3600 Transportation, Construction, Electronic Commerce, Agriculture, National Security, and License & Review
3683 Ex Parte Deferme 7,070,029 10/662,544 11879727 - (D) BARRETT 251 Harness, Dickey & Pierce, PLC (Tenneco) DOERRLER, WILLIAM CHARLES original KRAMER, DEVON C
3738 HEINZ KURZ GmbH MEDIZINTECHNIK Patent Owner, Appellant Ex Parte KURZ 6,579,317 09/933,619 14326632 - (D) SONG 103 STRIKER, STRIKER & STENBY JASTRZAB, JEFFREY R original GHERBI, SUZETTE JAIME J
Labels:
king
Monday, January 18, 2016
bicon, cat tech, king
custom search
REVERSED
Tech Center 3700 Mechanical Engineering, Manufacturing, and Products & Design
3777 Ex Parte Lloyd et al 11300264 - (D) HOSKINS 103 MCANDREWS HELD & MALLOY, LTD BRUTUS, JOEL F
"[C]laims are interpreted with an eye toward giving effect to all terms in the claim." Bicon, Inc. v. Straumann Co., 441 F.3d 945, 950 (Fed. Cir. 2006); see also Cat Tech LLC v. TubeMaster, Inc., 528 F.3d 871, 885 (Fed. Cir. 2008) (refusing to adopt a claim construction which would render a claim limitation meaningless).
AFFIRMED
Tech Center 1700 Chemical & Materials Engineering
1798 Ex Parte Poulleau 11659123 - (D) GARRIS 103 SUGHRUE MION, PLLC WOODARD, JOYE L
Tech Center 2100 Computer Architecture and Software
2185 Ex Parte Biehler et al 12632196 - (D) MCMILLIN 103 SIEMENS CORPORATION DANG, KHANH
Tech Center 2400 Networking, Multiplexing, Cable, and Security
2469 Ex Parte Ali et al 13352985 - (D) MacDONALD 103 Fish & Richardson P.C. (Blackberry) WILLIAMS, JENEE LAUREN
Tech Center 2600 Communications
2628 Ex Parte SONG et al 12537013 - (D) CHEN 103 Artegis Law Group, LLP MISHLER, ROBIN J
Tech Center 2800 Semiconductors, Electrical and Optical Systems and Components
2862 Ex Parte Olmino 12437578 - (D) ULLAGADDI 103 LERNER GREENBERG STEMER LLP ANDERSON, LYNNE D
Tech Center 3600 Transportation, Construction, Electronic Commerce, Agriculture, National Security, and License & Review
3621 Ex Parte Furlong et al 10769117 - (D) FETTING 103 CAMPBELL STEPHENSON LLP WU, RUTAO
The particular labels attached to the codes that are associated are discernable only in the mind of the beholder, and such labels are afforded no patentable weight. King Pharm., Inc. v. Eon Labs, Inc., 616 F.3d 1267, 1279 (Fed. Cir. 2010). (“If we were to adopt Ngai’s position, anyone could continue patenting a product indefinitely provided that they add a new instruction sheet to the product.”).
King Pharmaceuticals Inc. v. Eon Labs Inc., 616 F.3d 1267, 95 USPQ2d 1833 (Fed. Cir. 2010) 2111.05 , 2112.01
3623 Ex Parte Markowitz et al 11752692 - (D) FETTING 103 ARMSTRONG TEASDALE LLP SWARTZ, STEPHEN S
3625 Ex Parte Oiwa 14115488 - (D) FETTING 101 SUGHRUE MION, PLLC GARG, YOGESH C
3683 Ex Parte COOK et al 12917119 - (D) MURPHY 103 Target Brands Inc. GARCIA-GUERRA, DARLENE
3696 Ex Parte Blythe 11965946 - (D) FETTING 112(1)/112(2) 103 HOFFMANN & BARON, LLP BERONA, KIMBERLY SUE
Tech Center 3700 Mechanical Engineering, Manufacturing, and Products & Design
3753 Ex Parte Baumann et al 11096369 - (D) BROWNE 103 JOHNSON & JOHNSON ROST, ANDREW J
3768 Ex Parte Hall et al 12741831 - (D) PER CURIAM 103 PHILIPS INTELLECTUAL PROPERTY & STANDARDS BOR, HELENE CATHERINE
3788 Ex Parte Latvala 12514190 - (D) LANEY 103 Birch, Stewart, Kolasch & Birch, LLP DESAI, KAUSHIKKUMAR A
REHEARING
DENIED
Tech Center 2100 Computer Architecture and Software
2135 Ex Parte Stansell et al 12234850 - (D) SZPONDOWSKI 103 CRGO LAW GOSSAGE, GLENN
REVERSED
Tech Center 3700 Mechanical Engineering, Manufacturing, and Products & Design
3777 Ex Parte Lloyd et al 11300264 - (D) HOSKINS 103 MCANDREWS HELD & MALLOY, LTD BRUTUS, JOEL F
"[C]laims are interpreted with an eye toward giving effect to all terms in the claim." Bicon, Inc. v. Straumann Co., 441 F.3d 945, 950 (Fed. Cir. 2006); see also Cat Tech LLC v. TubeMaster, Inc., 528 F.3d 871, 885 (Fed. Cir. 2008) (refusing to adopt a claim construction which would render a claim limitation meaningless).
AFFIRMED
Tech Center 1700 Chemical & Materials Engineering
1798 Ex Parte Poulleau 11659123 - (D) GARRIS 103 SUGHRUE MION, PLLC WOODARD, JOYE L
Tech Center 2100 Computer Architecture and Software
2185 Ex Parte Biehler et al 12632196 - (D) MCMILLIN 103 SIEMENS CORPORATION DANG, KHANH
Tech Center 2400 Networking, Multiplexing, Cable, and Security
2469 Ex Parte Ali et al 13352985 - (D) MacDONALD 103 Fish & Richardson P.C. (Blackberry) WILLIAMS, JENEE LAUREN
Tech Center 2600 Communications
2628 Ex Parte SONG et al 12537013 - (D) CHEN 103 Artegis Law Group, LLP MISHLER, ROBIN J
Tech Center 2800 Semiconductors, Electrical and Optical Systems and Components
2862 Ex Parte Olmino 12437578 - (D) ULLAGADDI 103 LERNER GREENBERG STEMER LLP ANDERSON, LYNNE D
Tech Center 3600 Transportation, Construction, Electronic Commerce, Agriculture, National Security, and License & Review
3621 Ex Parte Furlong et al 10769117 - (D) FETTING 103 CAMPBELL STEPHENSON LLP WU, RUTAO
The particular labels attached to the codes that are associated are discernable only in the mind of the beholder, and such labels are afforded no patentable weight. King Pharm., Inc. v. Eon Labs, Inc., 616 F.3d 1267, 1279 (Fed. Cir. 2010). (“If we were to adopt Ngai’s position, anyone could continue patenting a product indefinitely provided that they add a new instruction sheet to the product.”).
King Pharmaceuticals Inc. v. Eon Labs Inc., 616 F.3d 1267, 95 USPQ2d 1833 (Fed. Cir. 2010) 2111.05 , 2112.01
3623 Ex Parte Markowitz et al 11752692 - (D) FETTING 103 ARMSTRONG TEASDALE LLP SWARTZ, STEPHEN S
3625 Ex Parte Oiwa 14115488 - (D) FETTING 101 SUGHRUE MION, PLLC GARG, YOGESH C
3683 Ex Parte COOK et al 12917119 - (D) MURPHY 103 Target Brands Inc. GARCIA-GUERRA, DARLENE
3696 Ex Parte Blythe 11965946 - (D) FETTING 112(1)/112(2) 103 HOFFMANN & BARON, LLP BERONA, KIMBERLY SUE
Tech Center 3700 Mechanical Engineering, Manufacturing, and Products & Design
3753 Ex Parte Baumann et al 11096369 - (D) BROWNE 103 JOHNSON & JOHNSON ROST, ANDREW J
3768 Ex Parte Hall et al 12741831 - (D) PER CURIAM 103 PHILIPS INTELLECTUAL PROPERTY & STANDARDS BOR, HELENE CATHERINE
3788 Ex Parte Latvala 12514190 - (D) LANEY 103 Birch, Stewart, Kolasch & Birch, LLP DESAI, KAUSHIKKUMAR A
REHEARING
DENIED
Tech Center 2100 Computer Architecture and Software
2135 Ex Parte Stansell et al 12234850 - (D) SZPONDOWSKI 103 CRGO LAW GOSSAGE, GLENN
Monday, May 11, 2015
kuhle, king
custom search
REVERSED
Tech Center 2100 Computer Architecture and Software
2164 Ex Parte Subramaniam 12354974 - (D) ARBES 103 GRIFFITHS & SEATON PLLC (IBM) KUDDUS, DANIEL A
Tech Center 2400 Networking, Multiplexing, Cable, and Security
2491 Ex Parte Takala et al 12323737 - (D) BUI 103 Alston & Bird LLP Nokia Corporation and Alston & Bird LLP POTRATZ, DANIEL B
Tech Center 3700 Mechanical Engineering, Manufacturing, and Products & Design
3752 Ex Parte Wildfang 11908046 - (D) BROWNE 102 VOLPE AND KOENIG, P.C. JONAITIS, JUSTIN M
AFFIRMED-IN-PART
Tech Center 3600 Transportation, Construction, Electronic Commerce, Agriculture, National Security, and License & Review
3661 Ex Parte Basir et al 11830575 - (D) MAYBERRY 103 103 CARLSON, GASKEY & OLDS, P.C. LOUIE, WAE LENNY
Neither this disclosure nor Appellant's attorney argument supports a finding that it would not be a matter of design choice to have Funk's voice portal server 104 provide speech recognition for numbers, as well as words, to determine a destination for routing purposes. See, e.g., In re Kuhle, 526 F.2d 553 (CCPA 1975) (concluding that the use of claimed feature solves no stated problem and presents no unexpected result and "would be an obvious matter of design choice within the skill of the art") (citation omitted)
Kuhle, In re, 526 F.2d 553, 188 USPQ 7 (CCPA 1975) 2144.04
Tech Center 3700 Mechanical Engineering, Manufacturing, and Products & Design
3728 Ex Parte Westrup 13012720 - (D) STEPINA 103 103 CHERNOFF, VILHAUER, MCCLUNG & STENZEL, LLP ORTIZ, RAFAEL ALFREDO
AFFIRMED
Tech Center 1700 Chemical & Materials Engineering
1767 Ex Parte Bulluck et al 11199494 - (D) GARRIS 102/103 Egan, Peterman & Enders LLP. RIOJA, MELISSA A
We also emphasize that Appellants’ argument is undermined by legal precedent that, “[t]o anticipate, the prior art need only meet the inherently disclosed limitation to the extent the patented method does.” King Pharm., Inc. v. Eon Labs, Inc., 616 F.3d 1267, 1276 (Fed. Cir. 2010). That is, based on the record before us, it is reasonable to believe the compositions of Sellstrom inherently exhibit surface isotherms to the same extent as the identical compositions claimed by Appellants.
King Pharmaceuticals Inc. v. Eon Labs Inc., 616 F.3d 1267, 95 USPQ2d 1833 (Fed. Cir. 2010) 2111.05
Tech Center 2100 Computer Architecture and Software
2133 Ex Parte Djordjevic 12134380 - (D) HOMERE 112(2) 103 John S. Economou AYASH, MARWAN
2159 Ex Parte Gross 12191999 - (D) McMILLIN 103 PATENTBEST MAMILLAPALLI, PAVAN
Tech Center 2400 Networking, Multiplexing, Cable, and Security
2462 Ex Parte Friskney et al 11964534 - (D) HOMERE 102 Daniels IP Services LTD. MILLS, DONALD L
Tech Center 2600 Communications
2622 Ex Parte Anastas et al 12272547 - (D) DEJMEK 103 KILPATRICK TOWNSEND & STOCKTON LLP SASINOWSKI, ANDREW
2628 Ex Parte Noda 10911546 - (D) BOUDREAU 103 FISHMAN STEWART YAMAGUCHI PLLC JOHNSON, ALLISON WALTHALL
2637 Ex Parte Karstens 12043332 - (D) DEJMEK 112(1)/103 PATENTS ON DEMAND, P.A. IBM-RSW LI, SHI K
2641 Ex Parte Fomin et al 12040131 - (D) BEAMER 103 Norton Rose Fulbright US LLP Qualcomm LAI, DANIEL
Tech Center 3700 Mechanical Engineering, Manufacturing, and Products & Design
3741 Ex Parte Chaudhry 12441798 - (D) HOELTER 103 CARLSON, GASKEY & OLDS/PRATT & WHITNEY MEADE, LORNE EDWARD
3742 Ex Parte Dighe et al 12378167 - (D) MAYBERRY 103 PIETRAGALLO GORDON ALFANO BOSICK & RASPANTI, LLP NGUYEN, HUNG D
REVERSED
Tech Center 2100 Computer Architecture and Software
2164 Ex Parte Subramaniam 12354974 - (D) ARBES 103 GRIFFITHS & SEATON PLLC (IBM) KUDDUS, DANIEL A
Tech Center 2400 Networking, Multiplexing, Cable, and Security
2491 Ex Parte Takala et al 12323737 - (D) BUI 103 Alston & Bird LLP Nokia Corporation and Alston & Bird LLP POTRATZ, DANIEL B
Tech Center 3700 Mechanical Engineering, Manufacturing, and Products & Design
3752 Ex Parte Wildfang 11908046 - (D) BROWNE 102 VOLPE AND KOENIG, P.C. JONAITIS, JUSTIN M
AFFIRMED-IN-PART
Tech Center 3600 Transportation, Construction, Electronic Commerce, Agriculture, National Security, and License & Review
3661 Ex Parte Basir et al 11830575 - (D) MAYBERRY 103 103 CARLSON, GASKEY & OLDS, P.C. LOUIE, WAE LENNY
Neither this disclosure nor Appellant's attorney argument supports a finding that it would not be a matter of design choice to have Funk's voice portal server 104 provide speech recognition for numbers, as well as words, to determine a destination for routing purposes. See, e.g., In re Kuhle, 526 F.2d 553 (CCPA 1975) (concluding that the use of claimed feature solves no stated problem and presents no unexpected result and "would be an obvious matter of design choice within the skill of the art") (citation omitted)
Kuhle, In re, 526 F.2d 553, 188 USPQ 7 (CCPA 1975) 2144.04
Tech Center 3700 Mechanical Engineering, Manufacturing, and Products & Design
3728 Ex Parte Westrup 13012720 - (D) STEPINA 103 103 CHERNOFF, VILHAUER, MCCLUNG & STENZEL, LLP ORTIZ, RAFAEL ALFREDO
AFFIRMED
Tech Center 1700 Chemical & Materials Engineering
1767 Ex Parte Bulluck et al 11199494 - (D) GARRIS 102/103 Egan, Peterman & Enders LLP. RIOJA, MELISSA A
We also emphasize that Appellants’ argument is undermined by legal precedent that, “[t]o anticipate, the prior art need only meet the inherently disclosed limitation to the extent the patented method does.” King Pharm., Inc. v. Eon Labs, Inc., 616 F.3d 1267, 1276 (Fed. Cir. 2010). That is, based on the record before us, it is reasonable to believe the compositions of Sellstrom inherently exhibit surface isotherms to the same extent as the identical compositions claimed by Appellants.
King Pharmaceuticals Inc. v. Eon Labs Inc., 616 F.3d 1267, 95 USPQ2d 1833 (Fed. Cir. 2010) 2111.05
Tech Center 2100 Computer Architecture and Software
2133 Ex Parte Djordjevic 12134380 - (D) HOMERE 112(2) 103 John S. Economou AYASH, MARWAN
2159 Ex Parte Gross 12191999 - (D) McMILLIN 103 PATENTBEST MAMILLAPALLI, PAVAN
Tech Center 2400 Networking, Multiplexing, Cable, and Security
2462 Ex Parte Friskney et al 11964534 - (D) HOMERE 102 Daniels IP Services LTD. MILLS, DONALD L
Tech Center 2600 Communications
2622 Ex Parte Anastas et al 12272547 - (D) DEJMEK 103 KILPATRICK TOWNSEND & STOCKTON LLP SASINOWSKI, ANDREW
2628 Ex Parte Noda 10911546 - (D) BOUDREAU 103 FISHMAN STEWART YAMAGUCHI PLLC JOHNSON, ALLISON WALTHALL
2637 Ex Parte Karstens 12043332 - (D) DEJMEK 112(1)/103 PATENTS ON DEMAND, P.A. IBM-RSW LI, SHI K
2641 Ex Parte Fomin et al 12040131 - (D) BEAMER 103 Norton Rose Fulbright US LLP Qualcomm LAI, DANIEL
Tech Center 3700 Mechanical Engineering, Manufacturing, and Products & Design
3741 Ex Parte Chaudhry 12441798 - (D) HOELTER 103 CARLSON, GASKEY & OLDS/PRATT & WHITNEY MEADE, LORNE EDWARD
3742 Ex Parte Dighe et al 12378167 - (D) MAYBERRY 103 PIETRAGALLO GORDON ALFANO BOSICK & RASPANTI, LLP NGUYEN, HUNG D
Tuesday, April 21, 2015
astrazeneca, ngai, king
custom search
REVERSED
Tech Center 2100 Computer Architecture and Software
2155 Ex Parte Yates et al 11900931 - (D) DANG 103 EDELL, SHAPIRO, & FINNAN, LLC HERSHLEY, MARK E
2161 Ex Parte Szabo 11942556 - (D) FRAHM 102 Trellis IP Law Group/ Sony Corp. LE, HUNG D
2181 Ex Parte Nogueras et al 12135999 - (D) DIXON 103 Greg Goshorn, P.C. LEE, CHUN KUAN
Tech Center 2600 Communications
2647 Ex Parte Hulkkonen et al 12743343 - (D) JIVANI 102/103 Squire Patton Boggs (US) LLP Nokia Technologies Oy TRANDAI, CINDY HUYEN
Tech Center 3600 Transportation, Construction, Electronic Commerce, Agriculture, National Security, and License & Review
3652 Ex Parte Rother et al 12151965 - (D) HILL 103 MARK P. STONE HAGEMAN, MARK C
3657 Ex Parte Jolley et al 12258212 - (D) ASTORINO 103 BAKER BOTTS L.L.P. WILLIAMS, THOMAS J
Tech Center 3700 Mechanical Engineering, Manufacturing, and Products & Design
3766 Ex Parte Singhal et al 11526514 - (D) WIEKER 112(2)/103 SHUMAKER & SIEFFERT , P.A PATEL, NATASHA
AFFIRMED-IN-PART
Tech Center 2800 Semiconductors, Electrical and Optical Systems and Components
2813 Ex Parte Zundel et al 12186034 - (D) HANLON 103 103 DICKE, BILLIG & CZAJA NICELY, JOSEPH C
AFFIRMED
Tech Center 1600 Biotechnology and Organic Chemistry
1633 Ex Parte Connor et al 11407446 - (D) PAULRAJ 103 McCarter & English / KCI NGUYEN, QUANG
Tech Center 1700 Chemical & Materials Engineering
1764 Ex Parte Asandei 12052947 - (D) McKELVEY 103 CANTOR COLBURN LLP KAUCHER, MARK S
1767 Ex Parte Hayashi et al 12280300 - (D) SMITH 102/103/obviousness-type double patenting BUCHANAN, INGERSOLL & ROONEY PC HEINCER, LIAM J
Tech Center 2100 Computer Architecture and Software
2183 Ex Parte Ferren et al 11292207 - (D) KRIVAK 112(2)/102/103 Constellation Law Group, PLLC FAHERTY, COREY S
Tech Center 2400 Networking, Multiplexing, Cable, and Security
2435 Ex Parte Shapiro 11132923 - (D) FRAHM 103 Wolfe-SBMC SCHWARTZ, DARREN B
2442 Ex Parte Faraj 11837024 - (D) SHIANG 101 103 Kennedy Lenart Spraggins LLP IBM (ROC-BKLS) MACILWINEN, JOHN MOORE JAIN
2466 Ex Parte Khuc 11434841 - (D) TROCK 103 SPRINT OH, ANDREW CHUNG SUK
2476 Ex Parte Wakumoto 11680089 - (D) BUI 102/103/obviousness-type double patenting HEWLETT-PACKARD COMPANY GHAFOERKHAN, FAIYAZKHAN
Tech Center 2600 Communications
2644 Ex Parte Hurtta et al 12213551 - (D) BAER 103 Mintz Levin/Nokia Technologies Oy HO, HUY C
2657 Ex Parte Bollenbacher et al 12130934 - (D) DIXON 103 CRGO LAW STEVEN M. GREENBERG PULLIAS, JESSE SCOTT
Tech Center 3700 Mechanical Engineering, Manufacturing, and Products & Design
3725 Ex Parte Schultz 12757366 - (D) GOODSON 103 41.50 103 FAY SHARPE LLP LEWIS, JUSTIN V
In essence, Appellant argues that the illustrations functionally interrelate with the mat because they represent instructions for using the mat to carry out inspection and cleaning. Yet the Federal Circuit’s precedents have “foreclosed the argument that simply adding new instructions to a known product creates the functional relationship necessary to distinguish the product from the prior art.” AstraZeneca LP v. Apotex Inc., 633 F.3d 1042, 1065 (Fed. Cir. 2010) (citing In re Ngai, 367 F.3d 1336, 1339 (Fed. Cir. 2004)). In Ngai, the court found that, in a kit claim, recited instructions for using the kit were not entitled to patentable weight because “the printed matter in no way depends on the kit, and the kit does not depend on the printed matter. All that the printed matter does is teach a new use for an existing product.” Ngai, 367 F.3d at 1339. Likewise, here, the illustrations on the mat do not depend on the mat, and the mat does not depend on the illustrations. The illustrations simply convey information to a user about cleaning and inspection operations that can be carried out on the mat.
“The rationale behind [the printed matter] line of cases is preventing the indefinite patenting of known products by the simple inclusion of novel, yet functionally unrelated limitations.” King Pharm., 616 F.3d at 1279 (Fed. Cir. 2010); see also Ngai, 367 F.3d at 1339 (“If we were to adopt Ngai’s position, anyone could continue patenting a product indefinitely provided that they add a new instruction sheet to the product.”). In this case, permitting Appellant to distinguish the prior art based on the contents of the illustrations appearing on the mat would allow continued patenting of a known product by the mere inclusion of novel non-functional descriptive material.
Ngai, In re, 367 F.3d 1336, 70 USPQ2d 1862 (Fed. Cir. 2004) 2112.01
King Pharmaceuticals Inc. v. Eon Labs Inc., 616 F.3d 1267, 95 USPQ2d 1833 (Fed. Cir. 2010) 2111.05
3762 Ex Parte Kelly et al 12423407 - (D) PAULRAJ 103 GARLICK & MARKISON LEVICKY, WILLIAM J
3779 Ex Parte SUZUSHIMA et al 11539421 - (D) ADAMS 102 OSTROLENK FABER LLP NEWTON, ALEXANDRA L
3788 Ex Parte Erickson et al 13013331 - (D) JESCHKE 102/103/obviousness-type double patenting SEAGER, TUFTE & WICKHEM, LLC STASHICK, ANTHONY D
REHEARING
DENIED
Tech Center 2100 Computer Architecture and Software
2127 Ex Parte Ferren et al 10909132 - (D) EVANS 102 IV - SUITER SWANTZ PC LLO RAO, SHEELA S
REEXAMINATION
REVERSED
Tech Center 2800 Semiconductors, Electrical and Optical Systems and Components
2838 VICOR CORPORATION Requester v. SYNQOR, INC. Patent Owner and Appellant Ex Parte 7,564,702 et al 11/901,263 95001853 - (D) MOORE 103 GREENBLUM & BERNSTEIN, P.L.C. Third Party Requester: Turner Boyd, LLP HEYMAN, JOHN S original NGUYEN, MATTHEW VAN
REHEARING
DENIED
Tech Center 3700 Mechanical Engineering, Manufacturing, and Products & Design
3714 HASBRO, INC., Requester, v. GANZ, Patent Owner. Ex Parte 7,677,948 B2 et al 11/027,880 95001341 - (D) SIU 103 Pearne & Gordon LLP for THIRD PARTY REQUESTER: PERKINS COIE L.L.P. KISS, ERIC B original AHMED, MASUD
REVERSED
Tech Center 2100 Computer Architecture and Software
2155 Ex Parte Yates et al 11900931 - (D) DANG 103 EDELL, SHAPIRO, & FINNAN, LLC HERSHLEY, MARK E
2161 Ex Parte Szabo 11942556 - (D) FRAHM 102 Trellis IP Law Group/ Sony Corp. LE, HUNG D
2181 Ex Parte Nogueras et al 12135999 - (D) DIXON 103 Greg Goshorn, P.C. LEE, CHUN KUAN
Tech Center 2600 Communications
2647 Ex Parte Hulkkonen et al 12743343 - (D) JIVANI 102/103 Squire Patton Boggs (US) LLP Nokia Technologies Oy TRANDAI, CINDY HUYEN
Tech Center 3600 Transportation, Construction, Electronic Commerce, Agriculture, National Security, and License & Review
3652 Ex Parte Rother et al 12151965 - (D) HILL 103 MARK P. STONE HAGEMAN, MARK C
3657 Ex Parte Jolley et al 12258212 - (D) ASTORINO 103 BAKER BOTTS L.L.P. WILLIAMS, THOMAS J
Tech Center 3700 Mechanical Engineering, Manufacturing, and Products & Design
3766 Ex Parte Singhal et al 11526514 - (D) WIEKER 112(2)/103 SHUMAKER & SIEFFERT , P.A PATEL, NATASHA
AFFIRMED-IN-PART
Tech Center 2800 Semiconductors, Electrical and Optical Systems and Components
2813 Ex Parte Zundel et al 12186034 - (D) HANLON 103 103 DICKE, BILLIG & CZAJA NICELY, JOSEPH C
AFFIRMED
Tech Center 1600 Biotechnology and Organic Chemistry
1633 Ex Parte Connor et al 11407446 - (D) PAULRAJ 103 McCarter & English / KCI NGUYEN, QUANG
Tech Center 1700 Chemical & Materials Engineering
1764 Ex Parte Asandei 12052947 - (D) McKELVEY 103 CANTOR COLBURN LLP KAUCHER, MARK S
1767 Ex Parte Hayashi et al 12280300 - (D) SMITH 102/103/obviousness-type double patenting BUCHANAN, INGERSOLL & ROONEY PC HEINCER, LIAM J
Tech Center 2100 Computer Architecture and Software
2183 Ex Parte Ferren et al 11292207 - (D) KRIVAK 112(2)/102/103 Constellation Law Group, PLLC FAHERTY, COREY S
Tech Center 2400 Networking, Multiplexing, Cable, and Security
2435 Ex Parte Shapiro 11132923 - (D) FRAHM 103 Wolfe-SBMC SCHWARTZ, DARREN B
2442 Ex Parte Faraj 11837024 - (D) SHIANG 101 103 Kennedy Lenart Spraggins LLP IBM (ROC-BKLS) MACILWINEN, JOHN MOORE JAIN
2466 Ex Parte Khuc 11434841 - (D) TROCK 103 SPRINT OH, ANDREW CHUNG SUK
2476 Ex Parte Wakumoto 11680089 - (D) BUI 102/103/obviousness-type double patenting HEWLETT-PACKARD COMPANY GHAFOERKHAN, FAIYAZKHAN
Tech Center 2600 Communications
2644 Ex Parte Hurtta et al 12213551 - (D) BAER 103 Mintz Levin/Nokia Technologies Oy HO, HUY C
2657 Ex Parte Bollenbacher et al 12130934 - (D) DIXON 103 CRGO LAW STEVEN M. GREENBERG PULLIAS, JESSE SCOTT
Tech Center 3700 Mechanical Engineering, Manufacturing, and Products & Design
3725 Ex Parte Schultz 12757366 - (D) GOODSON 103 41.50 103 FAY SHARPE LLP LEWIS, JUSTIN V
In essence, Appellant argues that the illustrations functionally interrelate with the mat because they represent instructions for using the mat to carry out inspection and cleaning. Yet the Federal Circuit’s precedents have “foreclosed the argument that simply adding new instructions to a known product creates the functional relationship necessary to distinguish the product from the prior art.” AstraZeneca LP v. Apotex Inc., 633 F.3d 1042, 1065 (Fed. Cir. 2010) (citing In re Ngai, 367 F.3d 1336, 1339 (Fed. Cir. 2004)). In Ngai, the court found that, in a kit claim, recited instructions for using the kit were not entitled to patentable weight because “the printed matter in no way depends on the kit, and the kit does not depend on the printed matter. All that the printed matter does is teach a new use for an existing product.” Ngai, 367 F.3d at 1339. Likewise, here, the illustrations on the mat do not depend on the mat, and the mat does not depend on the illustrations. The illustrations simply convey information to a user about cleaning and inspection operations that can be carried out on the mat.
“The rationale behind [the printed matter] line of cases is preventing the indefinite patenting of known products by the simple inclusion of novel, yet functionally unrelated limitations.” King Pharm., 616 F.3d at 1279 (Fed. Cir. 2010); see also Ngai, 367 F.3d at 1339 (“If we were to adopt Ngai’s position, anyone could continue patenting a product indefinitely provided that they add a new instruction sheet to the product.”). In this case, permitting Appellant to distinguish the prior art based on the contents of the illustrations appearing on the mat would allow continued patenting of a known product by the mere inclusion of novel non-functional descriptive material.
Ngai, In re, 367 F.3d 1336, 70 USPQ2d 1862 (Fed. Cir. 2004) 2112.01
King Pharmaceuticals Inc. v. Eon Labs Inc., 616 F.3d 1267, 95 USPQ2d 1833 (Fed. Cir. 2010) 2111.05
3762 Ex Parte Kelly et al 12423407 - (D) PAULRAJ 103 GARLICK & MARKISON LEVICKY, WILLIAM J
3779 Ex Parte SUZUSHIMA et al 11539421 - (D) ADAMS 102 OSTROLENK FABER LLP NEWTON, ALEXANDRA L
3788 Ex Parte Erickson et al 13013331 - (D) JESCHKE 102/103/obviousness-type double patenting SEAGER, TUFTE & WICKHEM, LLC STASHICK, ANTHONY D
REHEARING
DENIED
Tech Center 2100 Computer Architecture and Software
2127 Ex Parte Ferren et al 10909132 - (D) EVANS 102 IV - SUITER SWANTZ PC LLO RAO, SHEELA S
REEXAMINATION
REVERSED
Tech Center 2800 Semiconductors, Electrical and Optical Systems and Components
2838 VICOR CORPORATION Requester v. SYNQOR, INC. Patent Owner and Appellant Ex Parte 7,564,702 et al 11/901,263 95001853 - (D) MOORE 103 GREENBLUM & BERNSTEIN, P.L.C. Third Party Requester: Turner Boyd, LLP HEYMAN, JOHN S original NGUYEN, MATTHEW VAN
REHEARING
DENIED
Tech Center 3700 Mechanical Engineering, Manufacturing, and Products & Design
3714 HASBRO, INC., Requester, v. GANZ, Patent Owner. Ex Parte 7,677,948 B2 et al 11/027,880 95001341 - (D) SIU 103 Pearne & Gordon LLP for THIRD PARTY REQUESTER: PERKINS COIE L.L.P. KISS, ERIC B original AHMED, MASUD
Labels:
astrazeneca
,
king
,
ngai
Monday, April 13, 2015
king, ngai, gulack
custom search
REVERSED
Tech Center 2100 Computer Architecture and Software
2198 Ex Parte MALCOLM 12040047 - (D) KHAN 102 LOWENSTEIN SANDLER LLP KABIR, MOHAMMAD H
Tech Center 2400 Networking, Multiplexing, Cable, and Security
2489 Ex Parte Yang et al 11140833 - (D) STRAUSS 103 Foley & Lardner LLP/ Broadcom Corporation PHILIPPE, GIMS S
Tech Center 3600 Transportation, Construction, Electronic Commerce, Agriculture, National Security, and License & Review
3662 Ex Parte Tava et al 12578405 - (D) GEIER 103 CROWELL & MORING LLP TO, TUAN C
Tech Center 3700 Mechanical Engineering, Manufacturing, and Products & Design
3742 Ex Parte LOVELESS et al 11833986 - (D) HORNER 103 INDEL, INC. VAN, QUANG T
AFFIRMED-IN-PART
Tech Center 3700 Mechanical Engineering, Manufacturing, and Products & Design
3729 Ex Parte Cherney et al 12262721 - (D) CAPP 103 103 DEERE & COMPANY PHAN, THIEM D
AFFIRMED
Tech Center 2400 Networking, Multiplexing, Cable, and Security
2451 Ex Parte Moore et al 11849507 - (D) MEDLOCK 103 Edell Shapiro & Finnan, LLC PATEL, DHAIRYA A
The rationale underlying the "printed matter" cases has been extended to the analysis of patentability of method claims. King Pharms. Inc. v. Eon Labs, Inc., 616 F.3d 1267, 1278-79 (Fed, Cir. 2010) (applying the "printed matter" reasoning to method claims containing an "informing" step that could be either printed or verbal instructions). In this case, the relevant inquiry is whether the recitation that the event statement conforms to the structure, " was seen to with ," as opposed to some other format structire, has a "new and unobvious functional relationship" with the method. Id. at 1279.
There is no objective evidence of record that there is a functional relationship between the format structure of the event statement and the claimed method. Indeed, the only mention in claim 1 of the event statement is in the final "wherein clause", i.e., "wherein the generated metadata is converted to an event."
Regardless of the format of the event statement, the underlying method recited in claim 1 is the same. The specific format structure of the event statement does not depend on the method, and the method does not depend on the format of the structure of the event statement. As such, it constitutes non-functional descriptive material that may not be relied on for patentability. See In re Ngai, 367 F.3d 1336, 1339 (Fed. Cir. 2004); cf. In re Gulack, 703 F.2d 1381, 1385 (Fed. Cir 1983) (when descriptive material is not functionally related to the substrate, the descriptive material will not distinguish the invention from the prior art in terms of patentability).
King Pharmaceuticals Inc. v. Eon Labs Inc., 616 F.3d 1267, 95 USPQ2d 1833 (Fed. Cir. 2010) 2111.05
Ngai, In re, 367 F.3d 1336, 70 USPQ2d 1862 (Fed. Cir. 2004) 2112.01
Gulack, In re, 703 F.2d 1381, 217 USPQ 401 (Fed. Cir. 1983) 2112.01
Tech Center 3700 Mechanical Engineering, Manufacturing, and Products & Design
3744 Ex Parte Howard 11716493 - (D) BAHR 103 PRAXAIR, INC. PETTITT, JOHN F
REHEARING
DENIED
Tech Center 2100 Computer Architecture and Software
2135 Ex Parte Lubbers et al 11771980 - (D) STEPHENS 103 Hall Estill Attorneys at Law (Seagate - MKM) RIGOL, YAIMA
REVERSED
Tech Center 2100 Computer Architecture and Software
2198 Ex Parte MALCOLM 12040047 - (D) KHAN 102 LOWENSTEIN SANDLER LLP KABIR, MOHAMMAD H
Tech Center 2400 Networking, Multiplexing, Cable, and Security
2489 Ex Parte Yang et al 11140833 - (D) STRAUSS 103 Foley & Lardner LLP/ Broadcom Corporation PHILIPPE, GIMS S
Tech Center 3600 Transportation, Construction, Electronic Commerce, Agriculture, National Security, and License & Review
3662 Ex Parte Tava et al 12578405 - (D) GEIER 103 CROWELL & MORING LLP TO, TUAN C
Tech Center 3700 Mechanical Engineering, Manufacturing, and Products & Design
3742 Ex Parte LOVELESS et al 11833986 - (D) HORNER 103 INDEL, INC. VAN, QUANG T
AFFIRMED-IN-PART
Tech Center 3700 Mechanical Engineering, Manufacturing, and Products & Design
3729 Ex Parte Cherney et al 12262721 - (D) CAPP 103 103 DEERE & COMPANY PHAN, THIEM D
AFFIRMED
Tech Center 2400 Networking, Multiplexing, Cable, and Security
2451 Ex Parte Moore et al 11849507 - (D) MEDLOCK 103 Edell Shapiro & Finnan, LLC PATEL, DHAIRYA A
The rationale underlying the "printed matter" cases has been extended to the analysis of patentability of method claims. King Pharms. Inc. v. Eon Labs, Inc., 616 F.3d 1267, 1278-79 (Fed, Cir. 2010) (applying the "printed matter" reasoning to method claims containing an "informing" step that could be either printed or verbal instructions). In this case, the relevant inquiry is whether the recitation that the event statement conforms to the structure, "
There is no objective evidence of record that there is a functional relationship between the format structure of the event statement and the claimed method. Indeed, the only mention in claim 1 of the event statement is in the final "wherein clause", i.e., "wherein the generated metadata is converted to an event."
Regardless of the format of the event statement, the underlying method recited in claim 1 is the same. The specific format structure of the event statement does not depend on the method, and the method does not depend on the format of the structure of the event statement. As such, it constitutes non-functional descriptive material that may not be relied on for patentability. See In re Ngai, 367 F.3d 1336, 1339 (Fed. Cir. 2004); cf. In re Gulack, 703 F.2d 1381, 1385 (Fed. Cir 1983) (when descriptive material is not functionally related to the substrate, the descriptive material will not distinguish the invention from the prior art in terms of patentability).
King Pharmaceuticals Inc. v. Eon Labs Inc., 616 F.3d 1267, 95 USPQ2d 1833 (Fed. Cir. 2010) 2111.05
Ngai, In re, 367 F.3d 1336, 70 USPQ2d 1862 (Fed. Cir. 2004) 2112.01
Gulack, In re, 703 F.2d 1381, 217 USPQ 401 (Fed. Cir. 1983) 2112.01
Tech Center 3700 Mechanical Engineering, Manufacturing, and Products & Design
3744 Ex Parte Howard 11716493 - (D) BAHR 103 PRAXAIR, INC. PETTITT, JOHN F
REHEARING
DENIED
Tech Center 2100 Computer Architecture and Software
2135 Ex Parte Lubbers et al 11771980 - (D) STEPHENS 103 Hall Estill Attorneys at Law (Seagate - MKM) RIGOL, YAIMA
Monday, January 13, 2014
gulack, bernhart, lowry, xiao, king, ngai
the blogger search function has been broken for months, google knows this, to search for names (ie examiner's name or a company) use custom search (google cse) below. to search for cases use tabs above
custom search
REVERSED
Tech Center 1700 Chemical & Materials Engineering
1732 Ex Parte Gadkaree et al 12599896 - (D) DELMENDO 103 CORNING INCORPORATED SAHA, BIJAY S
Tech Center 2800 Semiconductors, Electrical and Optical Systems and Components
2893 Ex Parte Ha et al 11307382 - (D) FRANKLIN 103 ISHIMARU & ASSOCIATES LLP ULLAH, ELIAS
Tech Center 3700 Mechanical Engineering, Manufacturing, and Products & Design
3774 Ex Parte Ryan et al 12070387 - (D) PER CURIAM 102/103 Medtronic CardioVascular WOZNICKI, JACQUELINE
AFFIRMED-IN-PART
Tech Center 2400 Networking, Multiplexing, Cable, and Security
2447 Ex Parte Potekhin et al 10144561 - (D) KOHUT 112(1)/103 101 WONG, CABELLO, LUTSCH, RUTHERFORD & BRUCCULERI, L.L.P. TANG, KAREN C
Tech Center 2600 Communications
2637 Ex Parte Xu et al 11707812 - (D) WINSOR 102/103 112(2)/obviousness-type double patenting GAZDZINSKI & ASSOCIATES, PC LEUNG, WAI LUN
Tech Center 2800 Semiconductors, Electrical and Optical Systems and Components
2856 Ex Parte Yamashita et al 12217899 - (D) GARRIS 102 102 HARNESS, DICKEY & PIERCE, P.L.C. DUNLAP, JONATHAN M
Tech Center 3600 Transportation, Construction, Electronic Commerce, Agriculture, National Security, and License & Review
3687 Ex Parte Fitzpatrick 11213577 - (D) FETTING 103 102 MACCORD MASON PLLC IWARERE, OLUSEYE
Finally, while claim 1 does recite “transaction data that represents a single client expenditure with a merchant in exchange for a plurality of products,” the manner or degree of representation is unspecified, and there is no recital of a sale, only an expenditure in exchange for products. Thus, this limitation is aspirational instead of functional or structural, and is perceptible only in the mind of the beholder.
In a non-precedential decision, our reviewing court reminded us of the applicability of the precedential In re Gulack, 703 F.2d 1381 (Fed. Cir.1983), In re Bernhart, 417 F.2d 1395 (CCPA 1969) and In re Lowry, 32 F.3d 1579 (Fed. Cir. 1994) decisions. We have held that patent applicants cannot rely on printed matter to distinguish a claim unless “there exists [a] new and unobvious functional relationship between the printed matter and the substrate.” In re Lowry, 32 F.3d 1579, 1582 (Fed. Cir. 1994) (citing In re Gulack, 703 F.2d 1381, 1386 (Fed.Cir.1983)
[T]he Board did not create a new “mental distinctions” rule in denying patentable weight . . . . On the contrary, the Board simply expressed the above-described functional relationship standard in an alternative formulation—consistent with our precedents—when it concluded that any given position label’s function . . . is a distinction “discernable only to the human mind.”. . . . see In re Lowry, 32 F.3d 1579, 1583 (Fed.Cir.1994) (describing printed matter as “useful and intelligible only to the human mind”) (quoting In re Bernhart, 417 F.2d 1395, 1399 (CCPA 1969)).
In re Xiao, 2011-1195 WL 4821929, at *3-4 (Fed. Cir. 2011) (Non-precedential). Thus non-functional descriptive material, being useful and intelligible only to the human mind, is given no patentable weight. “The rationale behind this line of cases is preventing the indefinite patenting of known products by the simple inclusion of novel, yet functionally unrelated limitations.” King Pharmaceuticals, Inc. v. Eon Labs, Inc., 616 F.3d 1267, 1279 (Fed Cir 2010). See also In re Ngai, 367 F.3d 1336, 1338 (Fed. Cir. 2004). (The relevant inquiry here is whether the additional instructional limitation has a “new and unobvious functional relationship” with the method, that is, whether the limitation in no way depends on the method, and the method does not depend on the limitation).
Gulack, In re, 703 F.2d 1381, 217 USPQ 401 (Fed. Cir. 1983) , 2112.01
DONNER 7: 153, 175 8: 1000
Lowry, In re, 32 F.3d 1579, 32 USPQ2d 1031 (Fed. Cir. 1994)
DONNER 6: 179; 8: 395, 1924
King Pharmaceuticals Inc. v. Eon Labs Inc., 616 F.3d 1267, 95 USPQ2d 1833 (Fed. Cir. 2010) 2111.05
Ngai, In re, 367 F.3d 1336, 70 USPQ2d 1862 (Fed. Cir. 2004) , 2112.01
DONNER 7: 153, 175 8: 1000
AFFIRMED
Tech Center 1700 Chemical & Materials Engineering
1768 Ex Parte Shiping 11862389 - (D) McKELVEY 103 CANTOR COLBURN LLP NERANGIS, VICKEY M
1784 Ex Parte Zhai et al 10912576 - (D) KALAN 103 STEPTOE & JOHNSON LLP SAMPLE, DAVID R
Tech Center 2100 Computer Architecture and Software
2186 Ex Parte Klein et al 11781374 - (D) HUME 102/103 DICKE, BILLIG & CZAJA TSAI, SHENG JEN
Tech Center 2400 Networking, Multiplexing, Cable, and Security
2477 Ex Parte Pantalone et al 11469680 - (D) STRAUSS 103 HARRITY & HARRITY, LLP ZHOU, YONG
Tech Center 2600 Communications
2645 Ex Parte Kraufvelin 11436772 - (D) BUI 103 Ditthavong Mori & Steiner, P.C. TORRES, MARCOS L
REEXAMINATION
AFFIRMED
Tech Center 3700 Mechanical Engineering, Manufacturing, and Products & Design
3761 THE PROCTER & GAMBLE COMPANY Requester, Respondent v. PLAYTEX PRODUCTS, INC. Patent Owner, Appellant 95001654 6,890,324 09/894,042 MARTIN 305/102/103 OHLANDT, GREELEY, RUGGIERO & PERLE, L.L.P. WILLIAMS, CATHERINE SERKE original KIDWELL, MICHELE M
custom search
REVERSED
Tech Center 1700 Chemical & Materials Engineering
1732 Ex Parte Gadkaree et al 12599896 - (D) DELMENDO 103 CORNING INCORPORATED SAHA, BIJAY S
Tech Center 2800 Semiconductors, Electrical and Optical Systems and Components
2893 Ex Parte Ha et al 11307382 - (D) FRANKLIN 103 ISHIMARU & ASSOCIATES LLP ULLAH, ELIAS
Tech Center 3700 Mechanical Engineering, Manufacturing, and Products & Design
3774 Ex Parte Ryan et al 12070387 - (D) PER CURIAM 102/103 Medtronic CardioVascular WOZNICKI, JACQUELINE
AFFIRMED-IN-PART
Tech Center 2400 Networking, Multiplexing, Cable, and Security
2447 Ex Parte Potekhin et al 10144561 - (D) KOHUT 112(1)/103 101 WONG, CABELLO, LUTSCH, RUTHERFORD & BRUCCULERI, L.L.P. TANG, KAREN C
Tech Center 2600 Communications
2637 Ex Parte Xu et al 11707812 - (D) WINSOR 102/103 112(2)/obviousness-type double patenting GAZDZINSKI & ASSOCIATES, PC LEUNG, WAI LUN
Tech Center 2800 Semiconductors, Electrical and Optical Systems and Components
2856 Ex Parte Yamashita et al 12217899 - (D) GARRIS 102 102 HARNESS, DICKEY & PIERCE, P.L.C. DUNLAP, JONATHAN M
Tech Center 3600 Transportation, Construction, Electronic Commerce, Agriculture, National Security, and License & Review
3687 Ex Parte Fitzpatrick 11213577 - (D) FETTING 103 102 MACCORD MASON PLLC IWARERE, OLUSEYE
Finally, while claim 1 does recite “transaction data that represents a single client expenditure with a merchant in exchange for a plurality of products,” the manner or degree of representation is unspecified, and there is no recital of a sale, only an expenditure in exchange for products. Thus, this limitation is aspirational instead of functional or structural, and is perceptible only in the mind of the beholder.
In a non-precedential decision, our reviewing court reminded us of the applicability of the precedential In re Gulack, 703 F.2d 1381 (Fed. Cir.1983), In re Bernhart, 417 F.2d 1395 (CCPA 1969) and In re Lowry, 32 F.3d 1579 (Fed. Cir. 1994) decisions. We have held that patent applicants cannot rely on printed matter to distinguish a claim unless “there exists [a] new and unobvious functional relationship between the printed matter and the substrate.” In re Lowry, 32 F.3d 1579, 1582 (Fed. Cir. 1994) (citing In re Gulack, 703 F.2d 1381, 1386 (Fed.Cir.1983)
[T]he Board did not create a new “mental distinctions” rule in denying patentable weight . . . . On the contrary, the Board simply expressed the above-described functional relationship standard in an alternative formulation—consistent with our precedents—when it concluded that any given position label’s function . . . is a distinction “discernable only to the human mind.”. . . . see In re Lowry, 32 F.3d 1579, 1583 (Fed.Cir.1994) (describing printed matter as “useful and intelligible only to the human mind”) (quoting In re Bernhart, 417 F.2d 1395, 1399 (CCPA 1969)).
In re Xiao, 2011-1195 WL 4821929, at *3-4 (Fed. Cir. 2011) (Non-precedential). Thus non-functional descriptive material, being useful and intelligible only to the human mind, is given no patentable weight. “The rationale behind this line of cases is preventing the indefinite patenting of known products by the simple inclusion of novel, yet functionally unrelated limitations.” King Pharmaceuticals, Inc. v. Eon Labs, Inc., 616 F.3d 1267, 1279 (Fed Cir 2010). See also In re Ngai, 367 F.3d 1336, 1338 (Fed. Cir. 2004). (The relevant inquiry here is whether the additional instructional limitation has a “new and unobvious functional relationship” with the method, that is, whether the limitation in no way depends on the method, and the method does not depend on the limitation).
Gulack, In re, 703 F.2d 1381, 217 USPQ 401 (Fed. Cir. 1983) , 2112.01
DONNER 7: 153, 175 8: 1000
Lowry, In re, 32 F.3d 1579, 32 USPQ2d 1031 (Fed. Cir. 1994)
DONNER 6: 179; 8: 395, 1924
King Pharmaceuticals Inc. v. Eon Labs Inc., 616 F.3d 1267, 95 USPQ2d 1833 (Fed. Cir. 2010) 2111.05
Ngai, In re, 367 F.3d 1336, 70 USPQ2d 1862 (Fed. Cir. 2004) , 2112.01
DONNER 7: 153, 175 8: 1000
AFFIRMED
Tech Center 1700 Chemical & Materials Engineering
1768 Ex Parte Shiping 11862389 - (D) McKELVEY 103 CANTOR COLBURN LLP NERANGIS, VICKEY M
1784 Ex Parte Zhai et al 10912576 - (D) KALAN 103 STEPTOE & JOHNSON LLP SAMPLE, DAVID R
Tech Center 2100 Computer Architecture and Software
2186 Ex Parte Klein et al 11781374 - (D) HUME 102/103 DICKE, BILLIG & CZAJA TSAI, SHENG JEN
Tech Center 2400 Networking, Multiplexing, Cable, and Security
2477 Ex Parte Pantalone et al 11469680 - (D) STRAUSS 103 HARRITY & HARRITY, LLP ZHOU, YONG
Tech Center 2600 Communications
2645 Ex Parte Kraufvelin 11436772 - (D) BUI 103 Ditthavong Mori & Steiner, P.C. TORRES, MARCOS L
REEXAMINATION
AFFIRMED
Tech Center 3700 Mechanical Engineering, Manufacturing, and Products & Design
3761 THE PROCTER & GAMBLE COMPANY Requester, Respondent v. PLAYTEX PRODUCTS, INC. Patent Owner, Appellant 95001654 6,890,324 09/894,042 MARTIN 305/102/103 OHLANDT, GREELEY, RUGGIERO & PERLE, L.L.P. WILLIAMS, CATHERINE SERKE original KIDWELL, MICHELE M
Subscribe to:
Posts
(
Atom
)